Official website of the International mRCC Database Consortium (IMDC), including an up-to-date IMDC Prognosis Risk Calculator (IMDC Criteria / Heng Criteria) in addition to all past and …

The IMDC (International Metastatic RCC Database Consortium) Risk Score for RCC predicts survival patients in metastatic renal cell carcinoma treated with systemic therapy.

mIMCD-3 is an inner medullary collecting duct (IMCD) cell line derived in 1991 by Michael Rauchman from a mouse transgenic for the early region of SV40 [Tg (SV40E)bri/7]. A tubule …

We sought to validate the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model in patients with metastatic renal cell carcinoma receiving next-line targeted …

We developed a novel risk scoring system for patients with mRCC treated with immune checkpoint inhibitors (ICIs). We performed a retrospective analysis of 100 ICI‐treated patients …

The International Metastatic RCC (mRCC) Database Consortium (IMDC) prognostic model has been utilized for stratification in phase III clinical trials that established contemporary first-line …

Risk classification may change over time and may help in selecting treatments such as immunotherapy. Legend: KPS = Karnofsky Performance Score (e.g., are cancer symptoms a …

2014年10月30日 · We have developed a novel 3D cell culture model that uses mouse inner-medullary collecting duct (mIMCD3) cells to generate epithelial spheroids. This model is …

2015年2月11日 · We sought to validate the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model in patients with metastatic renal cell carcinoma receiving …

75 – 80% of patients selecting 1 line mRCC treatment options have at least 1 of these risk factors, therefore classifying their mRCC as intermediate/poor risk. Risk classification may change …